A new SEC filing confirms that Kinetics Internet Portfolio held 1,875 Class A common shares in Ripple Labs valued at $246,318.75 as of June 30. The quarterly regulatory report became public in August and shows the New York-based mutual fund reported $248.28 million in net assets and $251.70 million in total assets. The Ripple position therefore represented about 0.0992% of net assets.
The latest disclosure does not establish that Kinetics purchased the position during the quarter. An earlier March 31 schedule of investments listed 1,875 Ripple preferred A shares with a fair value of $228,281 and a cost of $300,000. The June filing lists the same share count as Ripple Labs Inc Common A Shares and assigns a higher fair value. The unchanged quantity means the change may reflect a reclassification, conversion or revised description, but the filings do not explain it.
The reported value rose by approximately $18,038 between March 31 and June 30, an increase of about 7.9%. Because Ripple remains privately held, this is a fund valuation rather than a quoted exchange price. Kinetics classified the investment as a Level 3 holding, meaning the private shares rely on unobservable inputs rather than active market quotations.
The filing highlights the legal distinction between Ripple equity and XRP. Ripple stock gives the holder an equity interest in Ripple Labs, while XRP is a digital asset and does not provide shares, voting rights, dividends or a contractual claim on the company's profits. The two investments respond to different factors: Ripple shares reflect the value investors assign to the private company, while XRP's price depends on token demand, liquidity, supply conditions and broader crypto trading.
The disclosure also arrives as the SEC considers a proposed framework called Regulation Crypto Assets. However, the proposal does not turn private Ripple shares into XRP or treat the two instruments as equivalent. Ripple remains subject to the final judgment from its earlier SEC litigation, including a $125 million penalty and an injunction connected to certain institutional sales. Ripple has not announced an IPO date or filed a public registration statement, and company President Monica Long has said there is no specific listing timeline.
The verified development is narrower than some social media claims: a U.S. mutual fund held a small, privately valued position in Ripple Labs at quarter end. The filing confirms institutional equity exposure, but it does not show a new purchase, an IPO plan or direct investment in XRP.
